Two LymeX Innovators, One Mission: Advancing Reliable Lyme Diagnostics

Multichannel pipette tips filled in with reaction mixture to amplify DNA in plastic wells

Galaxy Diagnostics and Virginia Tech Unite to Strengthen Direct Detection Approaches for Lyme Disease By Nicole Danielle Bell, CEO of Galaxy Diagnostics and author of What Lurks in the Woods The Diagnostic Uncertainty Clinicians Face Clinicians evaluating patients with suspected tick-borne disease routinely manage diagnostic uncertainty. Prior exposure, immune variability, and timing-dependent antibody responses can… Continue reading Two LymeX Innovators, One Mission: Advancing Reliable Lyme Diagnostics

REPLAY: Uncovering What’s Missed: Advancing Detection for Elusive Tick-Borne Infections

Standard testing leaves too many tick-borne infections undetected. This clinical webinar explores advanced detection methods to help clinicians find what’s missed when symptoms persist or contradict test results.

REPLAY: How Vector-Borne Pathogens Evade the Immune System

Vector-borne pathogens don’t survive by chance, they survive by design. Through immune suppression, antigenic variation, and tissue sequestration, these organisms persist in the host while evading immune clearance and complicating diagnosis.

How Vector-Borne Pathogens Evade the Immune System

Learn about tick-borne pathogen immune evasion with Galaxy Diagnostics

By Jennifer C. Miller, PhD, Vice President of Clinical & Scientific Operations, Galaxy Diagnostics   Summary: Babesia, Bartonella, and Borrelia are three of the most clinically important tick-borne pathogens in North America, while simultaneously being three of the most diagnostically elusive. Each has evolved distinct biological strategies to hide from the host immune system, suppress… Continue reading How Vector-Borne Pathogens Evade the Immune System

Borreliosis and doxycycline treatment disrupt gut microbiota and immune responses in nonhuman primates

Human Babesia odocoilei and Bartonella spp. co‑infections in the Americas